Lupin rolls out generic oncology drug in US market

Drug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets in various strengths. This product is bioequivalent to Sprycel Tablets. It is indicated for adults with Philadelphia chromosome-positive chronic myeloid leukemia. The US market for Dasatinib Tablets had significant sales.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WhdD0eY
via IFTTT